Trial Profile
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Feb 2023
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 13 Feb 2023 Planned End Date changed from 22 Oct 2022 to 22 Oct 2024.
- 13 Feb 2023 Planned primary completion date changed from 22 Oct 2022 to 22 Oct 2024.
- 08 Nov 2021 Planned number of patients changed from 100 to 200.